Clopidogrel Tablets Manufacturer in India

Strava Healthcare is a leading manufacturer of clopidogrel tablets in India mainly for pharmaceutical segments, hospital supply chains, and for the export markets. Clopidogrel is an antiplatelet agent which permanently blocks the P2Y12 receptor on platelets, and it also assisting in lowering the threat of thrombotic cardiovascular events. It is also present in the list of WHO Essential Medicines and is one of the majorly prescribed cardiovascular drugs.

Therapeutic Indications

Manufacturing Quality

Clopidogrel tablets are manufactured under GMP conditions with batch testing for assay, dissolution, content uniformity, and related substances. Our facility maintains validated processes to ensure consistent API content and release profiles. Batch documentation and third-party COAs are available.

For B2B & Pharma Partners

Product Specifications

Parameter Details
Active Ingredient Clopidogrel Bisulfate
Strength 75 mg
Dosage Form Film-coated Tablet
Pack Sizes 10s, 30s blister; 100s, 500s bottle
Storage Below 30°C, protect from moisture
Shelf Life 36 Months
Manufacturer Strava Healthcare Private Limited

Frequently Asked Questions

A standard 75 mg dose gains significant platelet inhibition within 2 hours. A loading dose of 300–600 mg gains faster onset and is used in acute coronary syndrome settings.
Probably yes, clopidogrel should be stopped 5–7 days prior to elective surgery to lower down bleeding risk. This decision must always be made by the treating physician, weighing thrombotic risk against bleeding risk.
Omeprazole and esomeprazole can reduce clopidogrel’s antiplatelet effect by inhibiting CYP2C19, which is needed to activate clopidogrel. Pantoprazole is generally preferred when a PPI is necessary.
Yes. We supply clopidogrel tablets to regulated and semi-regulated international markets. COPP and dossier support are available on request.
Scroll to Top